
Senti Bio is seeking a highly motivated and experienced individual with experience in Analytical Development. The successful candidate will contribute to the advancement of Senti’s proprietary immunotherapeutic cell engineering platforms focused on genetically modified cellular therapies. The role will support the development of cell-based functional assays and the characterization of processes and products by flow cytometry. The successful candidate will support the new method development, which may include qualification activities, and will also collaborate across Tech Ops during the developmental/optimization phases in manufacturing the product. We are looking for someone with a technically strong background with flow cytometry assays and/or cell-based assays and strong cell culturing experience of adherent and suspension cells looking to build on their Analytical Development experience.

Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address.
For more information, please visit the Senti Bio website at https://www.sentibio.com.